ir.amphastar.com
Investors - Amphastar Pharmaceuticals, Inc.The Investor Relations website contains information about Amphastar Pharmaceuticals, Inc. business for stockholders, potential investors, and financial analysts.
http://ir.amphastar.com/
The Investor Relations website contains information about Amphastar Pharmaceuticals, Inc. business for stockholders, potential investors, and financial analysts.
http://ir.amphastar.com/
TODAY'S RATING
>1,000,000
Date Range
HIGHEST TRAFFIC ON
Tuesday
LOAD TIME
1.1 seconds
PAGES IN
THIS WEBSITE
20
SSL
EXTERNAL LINKS
9
SITE IP
206.200.251.19
LOAD TIME
1.062 sec
SCORE
6.2
Investors - Amphastar Pharmaceuticals, Inc. | ir.amphastar.com Reviews
https://ir.amphastar.com
The Investor Relations website contains information about Amphastar Pharmaceuticals, Inc. business for stockholders, potential investors, and financial analysts.
Events & Presentations - Amphastar Pharmaceuticals, Inc.
http://ir.amphastar.com/events.cfm
Annual Reports and Proxies. Nov 8, 2016. Amphastar Third Quarter Earnings Call. Amphastar Third Quarter Earnings Call. Please sign up for Email alerts. Sep 22, 2016. File is in Briefcase. Jun 13, 2014. Amphastar Roadshow Presentation 06-13-14. File is in Briefcase. Sep 8, 2016. 2016 Wells Fargo Healthcare Conference. Aug 8, 2016. Amphastar Second Quarter Earnings Call. Jun 7, 2016. Jefferies 2016 Healthcare Conference. May 12, 2016. Bank of America Merrill Lynch 2016 Healthcare Conference. May 9, 2016.
Quarterly Results - Amphastar Pharmaceuticals, Inc.
http://ir.amphastar.com/results.cfm
Annual Reports and Proxies. Amphastar Second Quarter Earnings Call. Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended June 30, 2016. Amphastar First Quarter Earnings Call. Amphastar Pharmaceuticals Reports Financial Results for the First Quarter Ended March 31, 2016. Amphastar Fourth Quarter Earnings Call. Amphastar Pharmaceuticals Reports Financial Results for the Fourth Quarter and Fiscal Year Ended December 31, 2015. Amphastar Third Quarter Earnings Call.
Ownership Profile - Amphastar Pharmaceuticals, Inc.
http://ir.amphastar.com/ownership-profile.cfm
Annual Reports and Proxies. Data is not available at this time. This site is intended for residents of the United States.
SEC Filings - Amphastar Pharmaceuticals, Inc.
http://ir.amphastar.com/sec.cfm
Annual Reports and Proxies. All Filings (excluding Section 16). Oct 5, 2016. Statement, of changes of beneficial ownership. File is in Briefcase. Sep 27, 2016. Statement, of changes of beneficial ownership. File is in Briefcase. Sep 22, 2016. Statement, of changes of beneficial ownership. File is in Briefcase. Sep 12, 2016. Statement, of changes of beneficial ownership. File is in Briefcase. Sep 2, 2016. Statement, of changes of beneficial ownership. File is in Briefcase. Aug 24, 2016. Aug 19, 2016.
Historic Stock Lookup - Amphastar Pharmaceuticals, Inc.
http://ir.amphastar.com/stocklookup.cfm
Annual Reports and Proxies. Adjusted historic prices for the week of October 31, 2016. Oct 31, 2016. Nov 1, 2016. Nov 2, 2016. Year End Stock Prices. This site is intended for residents of the United States.
TOTAL PAGES IN THIS WEBSITE
20
Careers | AMPHASTAR
http://www.amphastar.com/careers.html
Amphastar Pharmaceuticals, Inc. is a progressive, forward-looking company that will recognize your talents, challenge you, and reward your efforts competitively. We invite you to explore employment opportunities with Amphastar and its subsidiaries. We are over 1200 employees strong; developing, manufacturing and marketing quality pharmaceutical products at six (6) locations:. Amphastar Pharmaceuticals, Inc. Rancho Cucamonga, California 91730. International Medication Systems, Ltd. 1886 Santa Anita Ave.
Enoxaparin | AMPHASTAR
http://www.amphastar.com/enoxaparin.html
Safety Device User Guide. Safety Device User Guide. Enoxaparin Sodium Injection Professional Prescribing Information. Safety Device Instructional Video. This site is intended for residents of the United States.
Cortrosyn | AMPHASTAR
http://www.amphastar.com/cortrosyn.html
Triggers plasma cortisol response immediately; may be utilized to perform a 30-minute test of. Has been used for ACTH Stimulation testing for more than 20 years. Only 2 venipunctures necessary. Can be used in office-based or outpatient procedures. Why is the ACTH Stimulation Test Performed? Cortrosyn Professional Prescribing Information. This site is intended for residents of the United States.
Our Products | AMPHASTAR
http://www.amphastar.com/our-products.html
Is the generic equivalent to Lovenox indicated for the prophylaxis of deep vein thrombosis, which may lead to pulmonary embolism and the inpatient/outpatient treatment of acute deep vein thrombosis (see Enoxaparin Sodium Injection Full Prescribing Information. Enoxaparin is available in prefilled syringes with UltraSafe Needle Guard making it fully compliant with the Needlestick Safety and Prevention Act. Amphastar's Enoxaparin is available in seven dosage forms. Amphadase (hyaluronidase injection, USP).
About Us | AMPHASTAR
http://www.amphastar.com/about-us.html
Amphastar Pharmaceuticals, Inc., headquartered in Rancho Cucamonga, California, established in 1996, is a recognized specialty pharmaceutical company that uses state-of-the-art, cGMP compliant facilities to develop, manufacture, and market injectable and inhalation products. In addition to the Corporate Headquarters, Amphastar has five manufacturing facilities located in the United States, China and Europe along with a state-of-the-art New Drug Research Center.
Phytonadione | AMPHASTAR
http://www.amphastar.com/phytonadione.html
Phytonadione Injection Sales Sheet. Safety Device Instructional Video. This site is intended for residents of the United States.
Media/News | AMPHASTAR
http://www.amphastar.com/medianews.html
Welcome to Amphastar Pharmaceuticals’ Media/News where our Press Releases. Give you insight into what is happening now at Amphastar and other industry NEWS about our fast-growing, innovative company. We invite you to learn more about us at news and view postings of upcoming events that we believe are of interest to our customers and investors. Jack Zhang, Ph.D. Jason Shandell, MBA, JD. 11570 6th Street, Rancho Cucamonga, CA., USA. Generics, Specialty Pharmaceuticals, APIs. Utilizing our highly experience...
TOTAL LINKS TO THIS WEBSITE
9
American Renal
Skip to main content. Home and Peritoneal Dialysis. Take good care of the patients and the financial success will follow. Enable the nephrologist to practice as he/she sees appropriate. Provide the nephrologist the autonomy to make operational decisions. Acknowledge that facility staff members are a critical and valuable asset. Do everything possible to hire and retain the best possible staff. Listen to the practitioners and provide the tools needed to take excellent care of their patients. Nov 11, 2016.
Ameriprise Investor Relations
Skip to top site navigation. 21,930.11 ($M). 065) - (0.53) %. As of August 7, 2015 -. Minimum 20 minute delay. Minimum 20 minute delay. Q2 2015 Long Term Care Review and Other Items. Second Quarter 2015 Earnings Conference Call. Thursday, July 23, 2015. 2014 Online Annual Report. 2014 Annual Report (PDF). Q2 2015 Earnings Release. Q2 2015 Statistical Supplement. Columbia Threadneedle Investments Hires Jim Bumpus to Lead U.S. National Sales. Ameriprise Financial Declares Regular Quarterly Dividend. Electr...
Ameris Bank: your community bank for free checking, online checking and banking services.
Ameris Bank Investor Relations. Deposit and Loan Composition. News and Market Data. Sign in to your account. Ameris Bank Credit Card. Don't have internet banking? Ameris Bank Investor Relations. To learn more about how we can help you expand your financial possibilities, visit one of our locations or continue exploring our site. As of August 7, 2015. Minimum 20 minute delay. Ameris Bancorp Reports Financial Results For Second Quarter 2015. Ameris Bancorp Announces Completion Of Branch Acquisition.
Investor Relations - Amicus Therapeutics
Welcome from Chairman and CEO. Epidermolysis Bullosa (EB) Program. Patient Advocacy at Amicus. Grants and Charitable Donations. Annual Reports and Proxies. Sign Up for Email Alerts. Annual Reports and Proxies. Sign Up for Email Alerts. A passionate team with a purpose. As a monotherapy for Fabry disease, SD-101. For Epidermolysis Bullosa (EB), as well as novel enzyme replacement therapy (ERT) products for Fabry disease, Pompe disease, and other Lysosomal Storage Disorders. Apr 6, 2017. Apr 3, 2017.
Amicus Therapeutics, Inc. - Investor Relations
At the forefront of therapies for rare and orphan diseases. Welcome from chairman and CEO. Protein misfolding and disease. Posters, abstracts and publications. Patient advocacy at amicus. As a monotherapy and in combination with enzyme replacement therapy (ERT) for Fabry disease; and AT2220 (duvoglustat HCl). In combination with ERT for Pompe disease. View all ». Aug 5, 2015. Amicus Therapeutics Announces Second Quarter 2015 Financial Results and Corporate Updates. Jul 29, 2015. View all ».
Investors - Amphastar Pharmaceuticals, Inc.
Annual Reports and Proxies. We are a specialty pharmaceutical company that focuses primarily on developing, manufacturing, marketing, and selling technically-challenging generic and branded injectable and inhalation products. We currently manufacture and sell 15 products in the U.S. and are developing a portfolio of 13 generic and 7 branded injectable and inhalation products that primarily target markets with high technical barriers to entry. Leverage our research and development capabilities;. Amphastar...
Investors | Albany Molecular Research
Whitepapers and Trade Articles. Whitepapers and Trade Articles. Albany Molecular Research Inc. Investor Webcast: AMRI Acquires Gadea. Investor Webcast: AMRI Second Quarter Earnings. A Message from Bill Marth. Aug 4, 2015. AMRI Announces Second Quarter 2015 Results. Jul 21, 2015. AMRI to Announce Second Quarter 2015 Results. View all press releases ». Aug 25, 2015. Sep 14, 2015. View all events ». Albany Molecular Research Inc. provides global contract research and manufacturing services to the pharma...
Investor Relations | American Superconductor Corporation
Skip to main navigation. Generator and Drivetrain Solutions. Network Planning and Applications. Solar Inverter and Plant Solutions. Turbine Controls and Systems. Utility Reactive Power Solutions. Mar 30, 2018. CBS 60 Minutes segment on The Great Brain Robbery, featuring an interview with CEO, Dan McGahn. Feb 21, 2018. AMSC Announces $10 Million in D-VAR System Orders. D-VAR Systems Sales Expand into Mexico to Support Renewable Connectivity Applications and into Japan for Industrial Power Quality. AMSC to...
Investor Relations - AmTrust Financial Services
News, Financial Releases. Warranty and Specialty Risk. AmTrust is a multinational property and casualty insurer specializing in coverage for small businesses. We offer workers compensation insurance, extended warranty coverage, specialty middle-market property and casualty insurance and a host of related products and services. Gross Written Premiums. $ in Billions. Net Operating Earnings Per Share. Aug 5, 2015. Aug 4, 2015. Aug 4, 2015 at 10:00 AM ET. Jun 10, 2015 at 10:00 AM CT. News, Financial Releases.
株式会社 アミューズ
3/30(金)より 美しいぼろ布展 都築響一が見たBORO を開催. AmuseLantis Europe S.A.S. IR支援会社の株式会社オプティア が運営している、個人投資家向け企業情報ポータル equity story に弊社IR担当者のインタビューが掲載されています。 株主優待 抽選招待 のご案内 を、普通郵便で発送致しました。 弊社執行役員、アミューズシンガポール社長の宮野治彦によるコラム アジア エンタメ川柳 第1句 第37句をアップしました。
Corporate Profile
Annual Reports and Proxy Statements. OUR CORPORATE RESPONSIBILITY REPORT. As of August 7, 2015 -. Minimum 20 minute delay. We are American Water. Q2 2015 Earnings Call. Thursday, August 6, 2015. Q2 2015 Earnings Call Slides. Site contains all the information you would need to learn about American Water as a publicly-traded company and as an investment option. Here you can view and download our latest financial statements. Https:/ www.youtube.com/embed/MiZ1mTzE9gI. American Water Declares Quarterly Divide...
SOCIAL ENGAGEMENT